drugset / Trial / NCT00584909
A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study us to determine the best treatment for patients with endometrial cancer who are at an elevated risk for recurrence.
Timeline
- Start
- 2006-03
- Primary completion
- 2010-09
- Completion
- 2011-09
Outcome
Outcome not reported
Stopped (Enrollment): “low accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Paclitaxel | Small molecule | 175 mg/m2 | Intravenous |